SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Feb 28, 2005
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Feb. 28, 2005 · CIK: 0001279704 · Accession: 0001255294-05-000081
AI Filing Summary & Sentiment
File numbers found in text: 333-119366
Show Raw Text
CORRESP
1
filename1.htm
Common Horizons Acceleration Ltr
COMMON HORIZONS, INC.
February 28, 2005
THE UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Attn: Ms. Amanda McManus
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549-0405
Mail Stop 0409
Via fax: 202-942-9635
Re: Common Horizons,
Inc.
Registration Statement on Form SB-2
File No. 333-119366
Dear Ms. McManus:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
Common Horizons, Inc. (the “Company”) hereby requests acceleration of the
effective date of its Registration Statement on Form SB-2 to 3:00 p.m. eastern
standard time on March 1, 2005, or as soon thereafter as is practicable.
The Company acknowledges the following:
·
Should the Commission or the staff, acting pursuant to
delegated authority, declare the filing effective, it does not foreclose
the Commission from taking any action with respect to the
filing;
·
The action of the Commission or the staff, acting pursuant
to delegated authority, in declaring the filing effective, does not
relieve the company from its full responsibility for the adequacy and
accuracy of the disclosure in the filing; and
·
The Company may not assert this action as a defense in any
proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Thank you for your assistance. Please call with any
questions.
Common Horizons, Inc.
By:
/s/ Edward F.
Panos
Edward F. Panos
President, Chief Executive Officer, Chief Financial Officer &
Director
620 Tam O’Shanter
Las Vegas, Nevada 89109
Tele: (702) 413-1205
1